0shopping bag

💊 Buy IMFINZI / Durvalumab 120 mg / 2.4 mL Injection Vials Online @ HK Canada Pharmacy MP

Select your required Drug:

buy DURVALUMAB / IMFINZI 120 MG / 2.4 ML INFUSION VIAL at lowest price online

Imfinzi 120 mg / 2.4 mL Infusion Vial of AstraZeneca ( Brand Drug )

Quantity / Pack Price / Pack Get Discount Net Price  
1 Vial 965 96 US$ 868 ADD TO CART
2 Vial 1930 232 US$ 1698 ADD TO CART
4 Vial 3860 502 US$ 3358 ADD TO CART

Manufactured by AstraZeneca. Branded Drug for Durvalumab. Express Shipments sent from Australia/India/Thailand by Aramex / FedEx / DHL / UPS / USPS / EMS courier service.

Generic DURVALUMAB / Brand IMFINZI 120 mg / 2.4 mL Infusion Vial is used to treat Bladder more

Global Express Shipping :
at Actual Costs only

Superfast Delivery :
3-7 working days*

Rx Prescription Required
for Human Use

Ut Undertaking Required
for R&D Scholarly Studies

* All brand-names and trademarks are the property of their respective owners. Images are for reference only.
See Brand/Sales Disclaimer: The Brand names...

Brand/Sales Disclaimer: The Brand names and/or Images/Logos as used/mentioned above or elsewhere on this site are for the reference of the Generic Drugs/Medicines only. The drugs listing by the third party vendor pharmacies is an invitation to offer to sell a drug/medicine of that brand name only when expressly indicated in the drug name details. Unless otherwise mentioned as above, all drugs sold on this site are claimed by the drug manufacturers to be the Bio-equivalent Generics of the Branded Drugs as approved by the FDA of their specific countries. The mention of the brand name, in any case, is not an explicit or implicit claim on any patent / trade-mark held by that brand name drugs manufacturer / patent-holder. All the information, medical or general, is compiled from internet sources and is not claimed to be an authoritative opinion or source information of or its developers or owners or vendor pharmacies; viewers are requested to validate the information from their own informed sources and act on the advice thereon only and proceed to order placement after due acceptance of the Terms of Use / Policies. All the Pharmaceutical Drugs ordered on are sold and shipped directly from Third Party Legal Registered Pharmacies which may not be situated in your country and are approved for use for Human Treatment by the FDA of the manufacturing country. They can also be used for conducting any R&D/Test or Analysis/Scholarly studies.

** Products will be shipped from a Licensed Pharmacy of Belgium, Canada, Germany, India, Ireland, Italy, Mexico, Singapore, South Africa, Spain, Turkey etc.

Marketing & Advertising Disclosure: is an online...

Marketing & Advertising Disclosure: is an online pharmaceuticals marketplace serving as a platform for global buyers and legal registered pharmacy sellers from different countries to connect with each other. All our pharmacy seller clients are minutely vetted to ensure that they are a Legal Registered Pharmacy having all the legally required registrations and licenses issued by the relevant departments of their jurisdictional Government Authorities. All the medicine products on our site are posted on behalf of the Legal Seller Pharmacy, are openly available at any pharmacy in the Country of Export, do not contain any Narcotic drug or ingredients and do not require any additional export permission from any Government Authority from the country of origin. The site adheres to the Right to Internet Access, also known as the Right to Broadband or Freedom to Connect, that all people globally must be able to access the Internet in order to exercise and enjoy their rights to freedom of expression and opinion and other fundamental human rights, that states have a responsibility to ensure that Internet access is broadly available, and that states may not unreasonably restrict an individual's access to the Internet. In compliance to US Laws, this site does not claim to be an online pharmacy operating in the US, does not make any medical claims to any US Citizens and does not advertise or offer to sell any drugs to them for their personal consumption or treatment. Buyers from the US can order for the products only if they require it for any scholarly study / Research / Test or Analysis uses only. The owner of this site and of the products and services referred to on this site only provides a service where consumers can obtain and compare information about various products. The owner has no monetary stake in the product and services advertised on the site. The owner agrees to receive payment at the Free Will of the consumer for release to the Pharmacy on proof of shipment and this is the extent of their monetary connection.

*** We make Express Shipments to all these Countries:...

Buyer / Patient Reviews on buying

Generic Durvalumab / Brand Imfinzi
  • facebook
  • twitter
  • linkdin
  • instagrams
  • youtube
Reviews on

4.1 out of 5 stars

Testimonials Disclaimer :  IN ACCORDANCE WITH...

DURVALUMAB IMFINZI : Cost/Price, Dosage/Doses, Uses, Side Effects, Warnings etc. information

Generic DURVALUMAB / Brand IMFINZI 120mg Vial is useful for treating urothelial cancers which are locally advanced or metastatic in patients who suffer from progression of disease at the time of or followed by platinum consisting of chemotherapy or who suffer from progression of disease in twelve months of neo-adjuvant or adjuvant treatment with platinum containing chemotherapy. Durvalumab / Imfinzi medicine is also used in patients who have unresectable stage III non-small cell lung cancer (NSCLC) and whose disease has not progressed following simultaneous platinum-based chemotherapy and radiation therapy.

What are the international reference brand names of Generic drug Durvalumab? The actual Generic Drug and Base Medicine DURVALUMAB is sold internationally under the most common marketing brand(s) IMFINZI. See our lowest Durvalumab Imfinzi cost / prices at the top of this page.

What is the brief overview information on Generic durvalumab / Brand Imfinzi ? • Duralumab is an intravenenous injection to be given to patients who are adults for treating urothelial carcinoma. This medication has been approved by US FDA in the year 2017.

What is the Branded Drug Imfinzi / Generic durvalumab used for (Indications) ? Durvalumab is classified as a human immunoglobulin G1 kappa monoclonal antibody that is used fortreating adult patients who have urothelial cancer (bladder and other parts cancer) either advanced locally or metastatic. This medicine is effective in treating the patients with a progression of disease at the time of or following chemotherapy containing platinum with surgery or without surgery. This medicine acts by blocking the binding of the detah of the programmed cells ligand 1(PDL-1) on T-cells to PD-1 ans CD80 molecules. This helps the immune system to fight against the cancer cells.

When should Imfinzi / durvalumab medication not to be used (Contraindications) ? This medicine should be avoided under the following conditions :- • Allergy to the medicine • Disorder of the immune system or weak immunity system due to a recent organ transplant • Prevalence of any infection • If the patient is underage (18 years or less), or if the patient is pregnant and breastfeeding.

What’s the prescribed durvalumab Imfinzi dosage / dosing requirement? • The medicine should be infused into the system intravenously in the amount of 10 mg/kg. This should be given to the patient for 60 minutes over a period of 2 weeks until prescribed otherwise. • If any detrimental effect is spotted during the course of medicine, Durvalumab should be avoided. • If there is an infection of grade 1 or 2, the rate of dosage should be slowed down.

What to do if Generic durvalumab / Brand Imfinzi dosage is missed ?

What are the Brand Imfinzi / Generic durvalumab drug / pills uses? • The prescribed dosage amount must be put and mixed slowly in an intravenous bag that already has 0.9% sodium chloride or 5% Dextrose which should be gently mixed without shaking the solution. • The concentration of the diluted solution should be in the range of 1 mg/ml and 15 mg/ml. • The infusion should be carried on through a separate intravenous line for over a period of 60 m inutes. No other drug should be administered using the same line. • The medication after dilution should be applied immediately after its preparation else it should be stored in a cool place for 24 hours. The temperature for storage should be within the range of 20°C to 25°C, for a maximum time of 4 hours.

What are the Imfinzi durvalumab warnings and precautions before use ? • Patients who are under the treatmentof this drug should be tested for pneumonitis if suspectd by a radiographic imaging. • Patient should be tested for the presence of immune-mediated hepatitis by reporting the liver enzymes level. • A patient undergoing the therapy might suffer from diarrhea which can be treated with an anti-diarrheal drug. • The inimical effects of Durvalumab therapy may include diabetes, thyroid disorders, and hypopituitarism. Necessary care should be taken and hormone replacement therapy might be suggested for the same. • During the Durvalumab therapy a patient must undergo Kidney function test as they might develop nephritis. • If infections like osteomyelitis, sepsis, necrotizing fasciitis occur during the treatment, then the medication is to be immediately stopped.

What are durvalumab Imfinzi side effects ? • A patient may experience high body temperature, weakness, dizziness among the general symptoms. Cases of gastro-intestinal disease like diarrhea, appetite loss or hepatitis have also been recorded. • Swollen feet and meningitis can be another side effect of the medication. • The patient may also suffer from various respiratory diseases ( cough, breathlessness, pneumonia), skin diseases ( allergy, rash, eczema, acne, lichen planus ), endocrine problems such as disorders of the thyroid, diabetes, inflammation of the pituitary gland, urinary tract diseases ( kidney damage, infection), and other allergic reactions.

What are the other Brand name Imfinzi / Generic durvalumab Imfinzi warnings and precautions? • The unused Durvalumab injection should be junked immediately. • Before discharging the medicine to the patient, signs of particles or discoloration should be noticed and solution should be discarded if anything is found. • Contraception should be used by the patient for at least 3 months after the treatment and also during the treatment.

What are durvalumab Imfinzi medication interactions with other drugs? Chances of severe infection can occur if Durvalumab is administered with the following drugs: • Tofacitinib • Infliximab • Leflunomide and teriflunomide • Etanercept • Talimogene laherparepvec • Vaccines (MMR, influenza, rotavirus, varicella, smallpox, typhoid, yellow fever, BCG) • Golimumab,adalimumab, Natalizumab, Certolizumab, • Fingolimod

What are the storage conditions of Brand Name Imfinzi / Generic Drug durvalumab? • Should be stored in a cool place with temperature ranging from 2°C to 8°C. • The injection should not be shaken or frozen. • Extreme heat and moisture should be avoided while storing the injection.

To check drug availability, brand name, generic name, to know where to buy IMFINZI / Durvalumab 120 mg / 2.4 mL Injection Vial Online @ HK Canada Pharmacy Marketplace Co., how much does a drug cost and manufacturer information; and also to buy low cost / price FDA Approved drugs online in various countries like Australia, Bulgaria, China, Dominican Republic, Estonia, Ethiopia, France, Georgia, Gibraltar, Honduras, Hong Kong, Indonesia, Ireland, Israel, Japan, Jersey, Malaysia, Malta, Morocco, Netherlands, New Zealand, Nigeria, Norway, Philippines, Romania, Saudi Arabia, Singapore, South Korea, Switzerland, Taiwan, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. Other countries for which you can check the prices of this page medicine and from where we can accept orders ( subject to customs clearance by buyer ) are Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antigua, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canary Islands, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Congo, The Democratic Republic, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curacao, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guyana, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea Republic, Guinea-Bissau, Guinea-Equatorial, Guyana (British) , Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Nevis, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Reunion Island, Romania, Russia, Rwanda, Saint Helena, Saipan, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, Somaliland, South Africa, South Korea, South Sudan, Spain, Sri Lanka, St. Barthelemy, St. Eustatius, St. Kitts, St. Lucia, St. Maarten, St. Vincent, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syria, Tahiti, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turks and Caicos Islands, Tuvalu, UAE, Uganda, UK, Ukraine, Uruguay, USA, Uzbekistan, Vanuatu, Vatican City State, Venezuela, Vietnam, Virgin Islands (British) , Virgin Islands (US) , Yemen, Zambia and Zimbabwe.

The Generic Drug DURVALUMAB is sold internationally under the most common brand name(s) IMFINZI. Patients/Buyers search for this drug’s brand name(s) Imfinzi by typing the drug name and adding the keywords like ‘durvalumab cost' - 'imfinzi price' - 'imfinzi cost' - 'durvalumab price' - 'imfinzi injection' - 'durvalumab cost per dose' - 'durvalumab chemotherapy' - 'durvalumab injection' - 'imfinzi 500mg price' - 'imfinzi cost per year' - 'imfinzi durvalumab price' - 'imfinzi chemotherapy’ This drug is offered on our web platform under Our Guarantee of a 100% CUSTOMS CLEARED DELIVERY for Australia, Bulgaria, China, Dominican Republic, Estonia, Ethiopia, France, Georgia, Gibraltar, Honduras, Hong Kong, Indonesia, Ireland, Israel, Japan, Jersey, Malaysia, Malta, Morocco, Netherlands, New Zealand, Nigeria, Norway, Philippines, Romania, Saudi Arabia, Singapore, South Korea, Switzerland, Taiwan, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam & many other countries. We give a GUARANTEED! Lowest Cost, High Discount, Online Pharmacy Price for this drug: | Durvalumab / Imfinzi 120 mg / 2.4 mL Injection Vial |. With us, you BUY DIRECT from LEGAL PHARMACIES / WHOcGMP certified & FDA approved Manufacturers in Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK ; USA a complete range of Generic and Branded Drugs for Cancer, AIDS/HIV, Anticoagulants, Antiviral, Cholesterol, Diabetes, Chronic Kidney Disease CKD/Anemia, COPD, Hepatitis, Immunosuppressive and Osteoporosis treatment. Drugs bought from our platform are Guaranteed to be Genuine as approved by, but not limited to, the Drugs Approval authorities of the following countries : Australia : TGA - Therapeutic Goods Administration Canada : HC – Health Canada EU : EMEA - European Medicines Agency India : CDSCO - Central Drugs Standard Control Organization Mauritius : MHQL - Ministry of Health and Quality of Life NZ : MedSafe - Medicines and Medical Devices Safety Authority Singapore : HSA - Health Sciences Authority Turkey : TMMDA - Turkish Medicines and Medical Devices Agency UK : MHRA - Medicines and Healthcare products Regulatory Agency USA : USFDA - US Food and Drug Administration.
The above information has been sourced from MEDICINES ORG UK , is intended only to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

Imfinzi - Durvalumab : Package Insert / Prescribing Information Leaflet, Medication Guides & Instructions for Use

Patient Package Inserts (PPI), Medication Guides (MG), and Instructions for Use (IFU) are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients use the medicine safe and effectively and try to avoid serious adverse events. Not all medicines have patient information and if you have questions about your medicines you should always talk with your Healthcare Provider or Pharmacist.

Medication Guides are developed by the manufacturer, approved by the FDA, and required to be given to consumers each time the medication is dispensed. You may see a printable pdf copy of the Medication Guide / Patient Information Leaflet of Imfinzi - Durvalumab in English Arabic Bulgarian Chinese Dutch Filipino French Hebrew Japanese Korean Portuguese Romanian Russian Spanish Swedish Thai Turkish Vietnamese

Patient Information Videos on Imfinzi – Durvalumab

Video Contents & Copyright Disclaimer :  The above videos and any contents..

Blogs/Information on Imfinzi - Durvalumab